BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Naranjo M, Hassoun PM. Systemic Sclerosis-Associated Pulmonary Hypertension: Spectrum and Impact. Diagnostics (Basel) 2021;11:911. [PMID: 34065226 DOI: 10.3390/diagnostics11050911] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Cansu DÜ, Korkmaz C. Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment. Clin Rheumatol 2022. [DOI: 10.1007/s10067-022-06446-y] [Reference Citation Analysis]
2 Padala SD, Lao C, Solanki K, White D. Direct and indirect health-related costs of systemic sclerosis in New Zealand. Int J Rheum Dis 2022. [PMID: 36135601 DOI: 10.1111/1756-185X.14433] [Reference Citation Analysis]
3 Shah S, Denton CP. Scleroderma autoantibodies in guiding monitoring and treatment decisions. Curr Opin Rheumatol 2022. [PMID: 36082759 DOI: 10.1097/BOR.0000000000000904] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Tabeling C, González Calera CR, Lienau J, Höppner J, Tschernig T, Kershaw O, Gutbier B, Naujoks J, Herbert J, Opitz B, Gruber AD, Hocher B, Suttorp N, Heidecke H, Burmester GR, Riemekasten G, Siegert E, Kuebler WM, Witzenrath M. Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension. Front Immunol 2022;13:895501. [PMID: 35757687 DOI: 10.3389/fimmu.2022.895501] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ruopp NF, Cockrill BA. Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review. JAMA 2022;327:1379-91. [PMID: 35412560 DOI: 10.1001/jama.2022.4402] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 12.0] [Reference Citation Analysis]
6 Rubio JLC, Escobar EM, Centeno NO. Cardiac manifestations of rheumatic diseases. Medicina Clínica (English Edition) 2022;158:396. [DOI: 10.1016/j.medcle.2022.03.002] [Reference Citation Analysis]
7 Ruaro B, Salton F, Baratella E, Confalonieri P, Geri P, Pozzan R, Torregiani C, Bulla R, Confalonieri M, Matucci-cerinic M, Hughes M. An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients. Diagnostics 2022;12:616. [DOI: 10.3390/diagnostics12030616] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Callejas Rubio JL, Moreno Escobar E, Ortego Centeno N. Cardiac manifestations of rheumatic diseases. Med Clin (Barc) 2021:S0025-7753(21)00473-5. [PMID: 34736621 DOI: 10.1016/j.medcli.2021.07.013] [Reference Citation Analysis]
9 Torbicki A. Pulmonary Hypertension: Diagnosis and Management. Diagnostics (Basel) 2021;11:1066. [PMID: 34207897 DOI: 10.3390/diagnostics11061066] [Reference Citation Analysis]